Menu
Menu
Shree Renuka Sugar Ltd. has fully exited its Mauritius-based subsidiary, Shree Renuka Global Ventures Ltd., by selling its remaining 17.1% stake to Freeway Trading Ltd. This strategic move follows an earlier divestment in 2019 and aligns with the company's focus on strengthening its core operations in India, including sugar production and ethanol manufacturing.
Bharat Global Developers' Dubai-based subsidiary has secured Rs 251 crore worth of prestigious orders for processing and supplying high-value gemstones and refining precious metals. This significant deal is expected to boost the company's revenue and profit margins, marking a key milestone in their global expansion strategy.
Welspun Corp has secured significant contracts worth Rs 1,300 crore in the US for coated HSAW pipes, set to support natural gas pipeline projects. Despite recent challenges in the Indian stock market, the company remains optimistic about its growth prospects in North America and beyond. Dive into the details of these new orders and what they mean for Welspun's future.
Ratan Tata, one of India's most influential business leaders, passed away at 86, leaving behind a remarkable legacy that transformed the Tata Group into a global powerhouse. From the acquisition of Jaguar Land Rover to the ambitious launch of the Tata Nano and the introduction of Starbucks in India, Tata's visionary decisions reshaped multiple industries. explores his key business strategies, their impacts, and how his leadership continues to inspire future generations. Join us as we reflect on the enduring influence of Ratan Tata on the world of business.
Ratan Tata, the esteemed chairman emeritus of the Tata Group, has left an indelible mark on Indian industry and philanthropy. we explore his remarkable legacy, innovative leadership, and commitment to social responsibility that continues to inspire future generations.
Cipla Ltd. is set to enhance its presence in the Chinese pharmaceutical market by acquiring a 6.9% stake from local partner Jiangsu Xidi Pharmaceuticals. This strategic move will turn Cipla Jiangsu into a wholly owned subsidiary, allowing for greater operational control and the potential to expedite product supplies to the US market. In this blog, we delve into the details of the acquisition and its implications for Cipla's growth and strategy in China.